Skip to Content
Skip to Main Navigation
Skip to Local Navigation
Skip to Search
Contact TGA:
info@tga.gov.au
|
1800 020 653
|
More contact info
Translate
|
Subscribe
Therapeutic Goods Administration (TGA)
Australian Government Department of Health
Main menu
Home
Safety information
Report a problem or side effect
Reporting adverse events involving medicines, vaccines or medical devices
Report an issue with packaging or storage of a medicine
AEMS guidance for health professionals
AEMS guidance for sponsors
Help us promote adverse event reporting: promotional resources kit
Alerts
Current year alerts
All alerts
Recalls
About Australian recall actions
Recall actions database
Uniform recall procedure
Early warning system
Monitoring communications
About the Early Warning System
Early Warning System: consumer questions and answers
Early Warning System: health professional questions and answers
Prescription opioids hub
Black Triangle Scheme
Black Triangle Scheme: Information for sponsors
Medicine shortages
Safety information & education
Medicines safety
Medical devices safety
Database of Adverse Event Notifications (DAEN)
Consumers
Report a problem or side effect
Reporting adverse events involving medicines, vaccines or medical devices
Travelling with medicines and medical devices
Leaving Australia
Entering Australia
Helpful links for travellers
Buying medicines and medical devices online
Counterfeit medicines and devices
Can I import it?
Personal importation scheme
Medicinal cannabis: importation and the traveller's exemption
Medicines
How we regulate medicines
Prescription medicines
Complementary medicines
Over-the-counter (OTC) medicines
Vaccines
What's on my medicine label?
Medical devices
Medical devices overview
Transvaginal (urogynaecological) surgical mesh hub
Breast implant hub
Cosmetic injections
Medical device cyber security
Advertising hub
Consumer information & education
Safety information for consumers
Medicines & medical devices
Community Q&A
MedSearch | Medicine information search app
Other web resources for consumers
Medicinal cannabis products
Health professionals
Report a problem or side effect
Reporting adverse events involving medicines, vaccines or medical devices
Accessing unapproved products
Special access scheme
Authorised prescribers
Clinical trials
Personal import scheme
Accessing medicines during a medicine shortage
Access to medicinal cannabis products
Advertising
Medicines
Medical devices
Biologicals
Safety information
Other resources
Industry
SME Assist
Basics of therapeutic goods regulation
Overview of applying for market authorisation
Medical devices regulation: an introduction
When to engage with the TGA
Useful resources for business
Is my product a therapeutic good?
What classification is my medical device?
Which clinical trial scheme should I choose?
What type of GMP application do I require?
Training sessions
What do I require to have a listed medicine in the ARTG?
Regulation basics
How therapeutic goods are regulated in Australia
Australian Register of Therapeutic Goods
Industry educational materials
Legislation & legislative instruments
Advertising hub
Labelling & packaging
Ingredients in therapeutic goods
Exporting therapeutic goods
Importing therapeutic goods
Clinical trials
Cosmetics
Scientific guidelines
Safety information for industry
Prescription medicines
Australian Regulatory Guidelines for Prescription Medicines
Prescription medicines regulation basics
Standards and guidelines
Forms for prescription medicine sponsors
Regulatory decisions and notices
Over-the-counter medicines
OTC medicines regulation basics
Standards, guidelines and publications
Forms for OTC medicine sponsors
Regulatory decisions and notices
Complementary medicines
Complementary medicine regulation basics
Standards, guidelines and publications
Forms for complementary medicine sponsors
Complementary medicines reforms
Regulatory decisions and notices
Sunscreens
Sunscreens regulation basics
Standards, guidelines and publications
Sunscreen reforms
Medical devices & IVDs
Medical devices regulation basics
IVD medical devices regulation basics
Standards, guidelines and publications
Forms for medical device & IVD sponsors
Medical devices reforms
Regulatory decisions and notices
Biologicals
Australian Regulatory Guidelines for Biologicals
Regulatory framework for biologicals
Biological standards
Forms for the biologicals industry
Regulatory decisions and notices
Blood and blood components
Regulation of blood
Regulation of platelet-rich plasma (PRP), platelet-rich fibrin (PRF) and conditioned serum
Forms for the blood and blood components industry
Other therapeutic goods
Disinfectants, sterilants and sanitary products
Tampons & menstrual cups
Manufacturing therapeutic goods
Manufacturing basics
Manufacturing medicines
Manufacturing medical devices & IVDs
Manufacturing biologicals
Manufacturing blood and blood components
Manufacturing inspections
Forms for manufacturers
Notices for manufacturers
Notices about GMP clearance
Scheduling of medicines & poisons
Scheduling basics
Scheduling committees meeting dates and decisions timeframes
The Poisons Standard (the SUSMP)
Public notices about scheduling
State/Territory scheduling information
About the TGA
TGA basics
Who we are & what we do
What the TGA doesn't do
Structure
TGA plans & reports
TGA reforms
Publications
Forms
Freedom of information
Acronyms & glossary
TGA Internet site
Social media
Contact the TGA
How can we help?
TGA customer service standards
Report a perceived breach or questionable practices
Website feedback or error reporting
Translate this website
Educational materials
For consumers
For health professionals
For industry
For university students
Education priorities 2018-19
Advertising hub
Advertising basics, general information and enquiries
Advertising Code and guidance
Complaints and outcomes
Sanctions and penalties
Education, training and events
Regulatory decisions and announcements
Stakeholder engagement and reforms
Compliance and enforcement hub
Compliance management
Compliance actions and outcomes
News and information
Report a breach
Regulatory decisions & notices
Consent to import, supply or export goods that do not comply with standards
Cancellation requested by the sponsor - regulatory actions
Failure to pay annual charges - regulatory actions
TGA laboratory testing results
Decisions to withdraw medicines advertising approval
S19A approval notices
Committees
TGA statutory advisory committees
Other committees
Employment & job vacancies
Working for the TGA
Recruitment information
Living in Canberra
Fees and payments
Schedule of fees and charges
Payment options
Information & notices about TGA fees & payments
Cost recovery implementation statements
Forms (fees and payments)
Annual Charge Exemption (ACE) scheme
TGA Business Services
TGA Business services: getting started with the TGA
TGA Business services - how to use the site
TGA Business Services forms
International
International activities
International cooperation
Use of international assessments
TGA international engagement strategy
Links to international agencies & organisations
TGA Internet site archive
Archived committee information
Archived consultations & reviews
Archived media releases
Archived presentations
Archived regulatory decisions & notices
Archived TGA publications & articles
Archived Behind the news
News room
News & public notices
Latest news & updates
Media releases & statements
Behind the news
Newsletters & articles
Subscribe to updates
TGA tenders
TGA laboratory testing reports
Consultations & reviews
Open consultations & reviews
Closed consultations & reviews
About consultations
Consultation forecast
Medicines and Medical Devices Regulation Review hub
Events, training & presentations
Events & training
Presentations
Blog
TGA topics
Decrease the text size
Increase the text size
Print this page
Share
You are here
Home
»
Industry
»
Complementary medicines
»
Standards, guidelines and publications
Herbal materials & extracts
Equivalence of herbal extracts in complementary medicines
In Australia, herbal extracts can be approved for use as ingredients in complementary medicines or as complementary medicines themselves
Identification of herbal materials and extracts
The overarching principle for the identification of herbal starting materials is traceability to a primary source or certified herb.
Use of modified unprocessed herbal materials in complementary medicines
In Australia, herbal substances are regulated as ingredients in complementary medicines
The Therapeutic Goods Administration is part of the Health Products Regulation Group